These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 7634500

  • 1. The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism.
    Lee PJ, Patel A, Hindmarsh PC, Mowat AP, Leonard JV.
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):601-6. PubMed ID: 7634500
    [Abstract] [Full Text] [Related]

  • 2. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 3. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):493-500. PubMed ID: 11012575
    [Abstract] [Full Text] [Related]

  • 4. Prediction of premature atherosclerosis by endothelial dysfunction and increased intima-media thickness in glycogen storage disease types Ia and III.
    Yekeler E, Dursun M, Emeksiz E, Akkoyunlu M, Akyol Y, Demir F, Gökcay G, Demirkol M.
    Turk J Pediatr; 2007 Oct; 49(2):115-9. PubMed ID: 17907509
    [Abstract] [Full Text] [Related]

  • 5. Hepatic ultrasound findings in the glycogen storage diseases.
    Lee P, Mather S, Owens C, Leonard J, Dicks-Mireaux C.
    Br J Radiol; 1994 Nov; 67(803):1062-6. PubMed ID: 7820397
    [Abstract] [Full Text] [Related]

  • 6. A monocentric pilot study of an antioxidative defense and hsCRP in pediatric patients with glycogen storage disease type IA and III.
    Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S.
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):383-90. PubMed ID: 19073362
    [Abstract] [Full Text] [Related]

  • 7. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin.
    van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J.
    Fertil Steril; 2000 Jul; 74(1):49-58. PubMed ID: 10899496
    [Abstract] [Full Text] [Related]

  • 8. Muscle Ultrasound in Patients with Glycogen Storage Disease Types I and III.
    Verbeek RJ, Sentner CP, Smit GP, Maurits NM, Derks TG, van der Hoeven JH, Sival DA.
    Ultrasound Med Biol; 2016 Jan; 42(1):133-42. PubMed ID: 26437929
    [Abstract] [Full Text] [Related]

  • 9. An association among iron, copper, zinc, and selenium, and antioxidative status in dyslipidemic pediatric patients with glycogen storage disease types IA and III.
    Kalkan Ucar S, Coker M, Sözmen E, Goksen Simsek D, Darcan S.
    J Trace Elem Med Biol; 2010 Jan; 24(1):42-5. PubMed ID: 20122579
    [Abstract] [Full Text] [Related]

  • 10. Insulin and GH secretion in adolescent girls with irregular cycles: polycystic vs multifollicular ovaries.
    Villa P, Rossodivita A, Fulghesu AM, Cucinelli F, Barini A, Apa R, Belosi C, Lanzone A.
    J Endocrinol Invest; 2003 Apr; 26(4):305-11. PubMed ID: 12841537
    [Abstract] [Full Text] [Related]

  • 11. Polycystic ovaries and associated metabolic abnormalities in Indian subcontinent Asian women.
    Rodin DA, Bano G, Bland JM, Taylor K, Nussey SS.
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):91-9. PubMed ID: 9797852
    [Abstract] [Full Text] [Related]

  • 12. Fertility and pregnancy in women affected by glycogen storage disease type I, results of a multicenter Italian study.
    Sechi A, Deroma L, Lapolla A, Paci S, Melis D, Burlina A, Carubbi F, Rigoldi M, Di Rocco M.
    J Inherit Metab Dis; 2013 Jan; 36(1):83-9. PubMed ID: 22562700
    [Abstract] [Full Text] [Related]

  • 13. Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring.
    Halaby CA, Young SP, Austin S, Stefanescu E, Bali D, Clinton LK, Smith B, Pendyal S, Upadia J, Schooler GR, Mavis AM, Kishnani PS.
    Genet Med; 2019 Dec; 21(12):2686-2694. PubMed ID: 31263214
    [Abstract] [Full Text] [Related]

  • 14. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 15. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 16. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K, Keleştimur F, Bayram F, Sahin Y, Tutuş A.
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [Abstract] [Full Text] [Related]

  • 17. Glycogen storage disease in adults.
    Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, Chen YT, Crigler JF, Ferreira P, Haworth JC, Herman GE, Issenman RM, Keating JP, Linde R, Roe TF, Senior B, Wolfsdorf JI.
    Ann Intern Med; 1994 Feb 01; 120(3):218-26. PubMed ID: 8273986
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism.
    Lanzone A, Fulghesu AM, Pappalardo S, Proto C, Le Donne M, Andreani CL, Muscatello R, Caruso A, Mancuso S.
    Gynecol Obstet Invest; 1990 Feb 01; 29(2):149-53. PubMed ID: 2110544
    [Abstract] [Full Text] [Related]

  • 19. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries.
    Robinson S, Kiddy D, Gelding SV, Willis D, Niththyananthan R, Bush A, Johnston DG, Franks S.
    Clin Endocrinol (Oxf); 1993 Sep 01; 39(3):351-5. PubMed ID: 8222298
    [Abstract] [Full Text] [Related]

  • 20. Amino acid disturbances in type III glycogenosis: differences from type I glycogenosis.
    Slonim AE, Coleman RA, Moses S, Bashan N, Shipp E, Mushlin P.
    Metabolism; 1983 Jan 01; 32(1):70-4. PubMed ID: 6336817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.